Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Transitional Cell

Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.

417 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Transitional Cell trial results

Active, Not Recruiting

Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy

NCT04637594

Conditions
Carcinoma, Carcinoma, Transitional Cell, Locally Advanced Bladder Urothelial Carcinoma, +12 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 377 locations
View Trial Details
Active, Not Recruiting

Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors

NCT03252938

Conditions
Abdominal Neoplasms, Carcinoma, Carcinoma, Transitional Cell, +12 more
Locations
  • Helios Klinikum Bad Saarow Bad Saarow, Germany
  • Kliniken der Stadt Köln gGmbH, Studienzentrum der Lungenklinik, Krankenhaus Merheim Cologne, Germany
  • Universitätsklinikum Essen Essen, Germany
  • Agaplesion Markus Krankenhaus Frankfurter Diakonie Kliniken gGmbH Frankfurt, Germany
View Trial Details
Active, Not Recruiting

A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)

NCT06483334

Conditions
Carcinoma, Carcinoma, Transitional Cell, Locally Advanced Urothelial Carcinoma, +5 more
Locations
  • University of California San Francisco HDFCCC ( Site 4044) San Francisco, California, United States
  • University of Chicago Medical Center ( Site 4037) Chicago, Illinois, United States
  • Indiana University Melvin and Bren Simon Cancer Center ( Site 4011) Indianapolis, Indiana, United States
  • Dana-Farber Cancer Institute ( Site 4047) Boston, Massachusetts, United States
View all 25 locations
View Trial Details

Related conditions